Pfizer hops on transparency bandwagon with disclosures

Share this article:
Kindler: accelerating Pfizer's pipeline
Kindler: accelerating Pfizer's pipeline
Following the lead of peers like Lilly and GlaxoSmithKline, Pfizer announced plans to publicly disclose payments to US physicians, healthcare professionals and clinical investigators in excess of $500 per year, along with non-monetary items worth more than $25.

The policy includes payments to principal investigators, major academic institutions and research sites for clinical research. In a first, the company said, annual disclosures will include payments for conducting Phase I-IV clinical trials as well as for speaking and consulting.

The first report is slated to appear on the company's website in early 2010, and will include payments from July 1, 2009 on.  

“We are committed to taking the steps necessary to achieve greater transparency in our interactions with US healthcare professionals,” said chairman and CEO Jeff Kindler in a statement. “By disclosing payments to physicians, we are breaking down a major barrier and increasing the trust healthcare providers must have when prescribing our medicines. To be viewed as an open, candid and transparent company, we must address the concerns of our customers and take action. This new initiative does just that.”
Share this article:

Email Newsletters

More in News

Eli Lilly and BI's Jardiance hits shelves

Eli Lilly and BI's Jardiance hits shelves

The new SGLT-2 inhibitor is on shelves less than a month after FDA approval.

PhRMA Urges Court to Reject Off-Label Promotion Case

PhRMA Urges Court to Reject Off-Label Promotion Case

The Pharmaceutical Research and Manufacturers of America (PhRMA) says a California federal court should dismiss a whistleblower's False Claims Act suit against three drug companies on First Amendment grounds

Five things for Pharma Marketers to know: Tuesday, August 26

Five things for Pharma Marketers to know: Tuesday, ...

Merck and Pfizer pursue new pembrolizumab research, black box warnings are linked to fewer court visits, and the WHO says it needs $430M to fight Ebola.